When treating diarrhea concomitantly with nifuroxazide therapy, rehydration therapy should be performed.
Treatment of diarrhea in children under 3 years is recommended under the supervision of a doctor.
In the case of bacterial diarrhea with signs of systemic damage (worsening of the general condition, fever, symptoms of intoxication, or infection), you should consult your doctor to decide on the use of antibacterial agents of systemic action.
When symptoms of hypersensitivity (dyspnea, rash, itching) occur, stop taking the drug.
During therapy, alcohol is not allowed.
The drug Stopdiar contains sucrose. Patients with rare hereditary impairments of fructose tolerance, glucose-galactose malabsorption or insufficiency of sucrose and isomaltase should not take this drug.
In connection with the content of methylparahydroxybenzoate, Stopdiar can cause allergic reactions (possibly delayed).
In one small measuring spoon the suspension contains 0.09 XE (bread units), in one large measuring spoon the suspension contains 0.18 XE.
The daily dose of the suspension for children aged 1 month to 3 years contains 0.27 XE. The daily dose of the suspension for children aged 3 to 6 years contains 0.54 XE. The maximum daily dose of the suspension for children aged 6 to 18 years old contains 0.72 XE.
The daily dose of the suspension for adults contains 0.72 XE.